Tango Therapeutics Inc
NASDAQ:TNGX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Tango Therapeutics Inc
NASDAQ:TNGX
|
US |
|
A
|
Amadeus IT Group SA
XBER:AI3A
|
ES |
|
M
|
MetLife Inc
SWB:MWZ
|
US |
|
F
|
Flowers Foods Inc
F:FWF
|
US |
|
Eastwood Bio-Medical Canada Inc
XTSX:EBM
|
CA |
|
T
|
Thermo Fisher Scientific Inc
LSE:0R0H
|
US |
|
V
|
Vestas Wind Systems A/S
XBER:VWSA
|
DK |
|
Titan Machinery Inc
NASDAQ:TITN
|
US |
|
Abbott Laboratories
NYSE:ABT
|
US |
|
Sika AG
SIX:SIKA
|
CH |
|
S
|
Siam Wellness Group PCL
SET:SPA
|
TH |
|
T
|
Toray Industries Inc
DUS:TOR1
|
JP |
|
C
|
Constellation Software Inc
XBER:W9C
|
CA |
|
SSAB AB
LSE:0KII
|
SE |
|
M
|
Myriad Genetics Inc
DUS:MYD
|
US |
|
Aurelia Metals Ltd
ASX:AMI
|
AU |
|
K
|
Kelly Services Inc
XBER:KYSA
|
US |
|
Cleen Energy AG
F:ET1
|
AT |
Wall St Price Targets
TNGX Price Targets Summary
Tango Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
TNGX is 44.69 USD with a low forecast of 24.24 USD and a high forecast of 72.45 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TNGX's stock price target?
Price Target
44.69
USD
According to Wall Street analysts, the average 1-year price target for
TNGX is 44.69 USD with a low forecast of 24.24 USD and a high forecast of 72.45 USD.
What is the Revenue forecast for Tango Therapeutics Inc?
Projected CAGR
1%
The compound annual growth rate for Revenue over the next 3 years is 1%.